Glerelin Cancer Injection

Strength

22.5 mg

Brand

Glerelin

Composition

Leuprorelin 22.5 mg

Manufacturer

Glenmark Pharmaceuticals

Treatment

Cancer

Prescription/Non prescription

Prescription

Form

Injection

Therapeutic Uses

Used to treat children with Central Precocious Puberty (CPP)
For the palliative treatment of advanced prostate cancer in adults

Packaging Type

1 vial in box